Cited by 207Neuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on BehaviorTreatment of Major Depression

Neurotransmitter systems in the etiology of major neurological disorders: Emerging insights and therapeutic implications

Nimgampalle, Mallikarjuna, Chakravarthy, Harshini, Sharma, Sapana, Shree, Shruti, Bhat, Anoop Ramachandra, Pradeepkiran, Jangampalli Adi, Devanathan, Vasudharani·2023·Ageing Research Reviews

Abstract

Neurotransmitters serve as chemical messengers playing a crucial role in information processing throughout the nervous system, and are essential for healthy physiological and behavioural functions in the body. Neurotransmitter systems are classified as cholinergic, glutamatergic, GABAergic, dopaminergic, serotonergic, histaminergic, or aminergic systems, depending on the type of neurotransmitter secreted by the neuron, allowing effector organs to carry out specific functions by sending nerve impulses. Dysregulation of a neurotransmitter system is typically linked to a specific neurological disorder. However, more recent research points to a distinct pathogenic role for each neurotransmitter system in more than one neurological disorder of the central nervous system. In this context, the review provides recently updated information on each neurotransmitter system, including the pathways involved in their biochemical synthesis and regulation, their physiological functions, pathogenic roles in diseases, current diagnostics, new therapeutic targets, and the currently used drugs for associated neurological disorders. Finally, a brief overview of the recent developments in neurotransmitter-based therapeutics for selected neurological disorders is offered, followed by future perspectives in that area of research.

Integrity signals

Registry

Crossref · 10.1016/j.arr.2023.101994

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Excessive glutamate levels trigger neuronal death through excitotoxicity and are implicated in neurodegenerative disease pathogenesis, and glutamatergic signaling is influenced by the gut microbiome.

    “However, excessive glutamate levels trigger neuronal death through excitotoxicity and have been implicated in the pathogenesis of neurodegenerative diseases.534 Similar to the neurotransmitter systems discussed previously, glutamatergic signaling is influenced by the gut microbiome.465”

The citation lists haven’t been fetched yet

References 311 · Cited by 207

Authors
Nimgampalle, M., Chakravarthy, H., Sharma, S., Shree, S., Bhat, A. R., Pradeepkiran, J. A., & Devanathan, V.
Affiliations
  • Indian Institute of Science Education and Research, Tirupati (IN)
  • Texas Tech University (US)
Corresponding author
  • Chakravarthy, Harshini
  • Devanathan, Vasudharani
Venue
Ageing Research Reviews
Publisher
Elsevier BV
Published
2023-08
Volume
89
Pages
101994
ISSN
1568-1637 (ISSN-L)
OpenAlex
W4382404921
Cited by
207
References
311
Citations by year
2026: 64 · 2025: 88 · 2024: 48 · 2023: 7
FWCI
8.29
Type
journal article
Language
en
Open access
closed
Locations
  • Ageing Research Reviews (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Department of Science and Technology, Ministry of Science and Technology, India (CSIRAWARD/JRF-NET2021/10729, DST/INSPIRE Fellowship/2019/IF190622)
  • University Grants Commission (JUNE18-302735-ACTIVE)
  • Deutscher Akademischer Austauschdienst (91769874)
  • Indian Institute of Science Education and Research Tirupati
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
neurotransmitter systems, neurological disorders, cholinergic system, glutamatergic system, GABAergic system, dopaminergic system, serotonergic system, histaminergic system, therapeutic target, central nervous system disorders
MeSH terms
Humans, Nervous System Diseases, Neurotransmitter Agents, Excitatory Amino Acid Agents, Dopaminergic Neurons, Cholinergic Neurons, GABAergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review